Methods
Data source and data collection
This retrospective national cohort study was conducted using NTR data from all adult public-sector hospitals in Singapore. The NTR covers all public hospitals in Singapore, with coding and data collection conducted by trained trauma data coordinators with annual data quality checks (covering accuracy, reliability, completeness and validation) performed annually. Quarterly review of data capture is performed by the National Registry of Diseases Office. The registry inclusion criteria, data collection, data cleaning and data quality audit processes have been described in previous studies [
23‐
25].
Study design
Retrospective data from January 2015 to December 2017 was extracted and de-identified by the public hospital trauma units, with 1 site contributing data only for 2015–2016, and another site providing only 2016 data. The associations between patient demographics, PMD types (MotPMD vs NonPMD), and outcomes of interest (injury severity and need for hospitalization) were examined.
Study population
We included patients aged 12 years and older who presented at the public-sector hospital emergency departments with PMD-related injuries. We excluded injuries related to: motorised wheelchairs, roller blades, and bicycles. Although pedestrians injured by PMDs would contribute to the burden of injury by PMDs, the data collection definitions for pedestrians injured by PMDs had not been standardized across the sites at the time of this study, as the NTR categories had focussed on PMD riders, hence we excluded pedestrians injured by PMDs.
Outcome measures
The primary outcome measure was higher injury severity, defined as injuries with an ISS of 9 or higher [
21,
22].
The second outcome measure was the need for hospital admission, as a proxy for healthcare utilization and costs.
Covariates
Patient demographics, PMD details, need for admission, and whether surgery was performed, were extracted from the NTR. Age was analyzed in these age-bands: 12–19 years, 20 to 39 years, 40 to 59 years, and 60 years or older.
PMDs were grouped into the following categories: MotPMDs (hoverboards/unicycles/e-wheels, motorised bicycles/e-bikes/powered assisted bicycles, motorised scooters/e-scooters, motorised skateboards), and NonPMDs (non-motorised scooters – including kick scooters or self-balancing scooters, and skateboards). PMD rider position was collected where available, where the patient was either the main rider, or a passenger/pillion rider on the PMD. For sites where information on injury prevention protective gear was collected, helmet use was examined.
Statistical testing
Overall patient characteristics were summarized by mean (standard deviation), median (inter-quartile range), or frequency (%) as appropriate.
Linear predictors of interest were re-categorised (for example, age into age-bands) for analysis. Logistic regression was used to examine the association between the variables and outcomes of interest.
Variables identified as having statistically significant associations (p < 0.05) in the univariate regression were included in the multivariable logistic regression model. Variables not statistically significant but clinically meaningful (gender) were also included.
As the morphology of injury due to different PMD types may differ, additional subgroup analysis was conducted of scooters only, comparing electric and non-electric scooters.
R version 3.4.3 was used.
Ethical issues
Ethical approval by the corresponding author’s institution’s institutional review board was granted, with waiver of informed consent granted as only secondary retrospective and de-identified data was used.
Discussion
To our knowledge, our study is the first to examine factors associated with injury severity and hospitalization in personal mobility device riders across a range of PMD types, using data that is nationally representative in an urban city state. Other studies have focused on specific types of PMDs. We found that MotPMD users had higher injury severity scores, with a greater proportion requiring surgical intervention compared to NonPMD users, as has been reported by other authors [
5,
18]. Our study, however, is one of the few that included a NonPMD comparator group, suggesting that MotPMD users are at higher risk of injury compared to NonPMD users.
MotPMD use and older age were identified as factors independently associated with severe injury. A similar pattern was found in the subgroup analysis of e-scooters, although this only reached statistical significance for severe injury, possibly due to smaller subgroup sample size. This is in keeping with the findings from studies conducted in China and Switzerland [
3,
13], focusing on pedal cycles versus electric-bicycle users, which also found higher injury severity for electric-bicycle users.
Older age was associated with higher risk of significant injury or admission, likely due to higher fall risk and frailty. Studies of motor vehicle crashes have also shown that the older patients tend to sustain higher injury severity and mortality [
25‐
29]. In common with motor vehicle crash-injured patients, older PMD riders are likely to have reduced physiological reserves and impaired response to injury [
30‐
32], coupled with comorbid conditions that predispose to injury or further reduce resilience [
32,
33], and propensity for fracture even with minor trauma [
34]. In addition, older riders are probably choosing to ride MotPMDs to overcome their pre-existing musculoskeletal problems, and these patients may be more frail than younger patients to begin with.
While our study did not specifically examine PMD rider behaviour, we did find that the majority of the MotPMD users did not use protective helmets, in line with the risk-taking profile found in other studies [
3,
13‐
17,
28].
MotPMD-related reasons such as higher travelling speeds [
4,
17,
19], and environmental issues such as lack of dedicated lanes vs usage of mixed-use conventional bicycle lanes, sidewalks or roads have also been proposed as contributory factors to injury [
18]. MotPMD-related legislation varies between countries. In the European Union, MotPMDs are barred from motor vehicle roads, and are allowed only on sidewalks at speeds < 6 km/hr. [
35]. In the United States, there is great variability between the states, with some permitting road usage [
35]. In Singapore, new legislation (Active Mobility Act) now restricts use to only sidewalks or shared bicycle lanes, but at maximum speed of 25 km/hr. Our study was conducted prior to the implementation of the new regulations. Future studies focusing on interventional strategies for injury prevention would be of great policy interest, such as examining the differences in incidence and economic burden of PMD-related injury before and after legislative rules controlling MotPMD use, especially given the significant association of MotPMDs with severe injury and admissions.
The main strength of our study was that it covered all the public-sector institutions nation-wide in an urban multi-ethnic population. However, the use of NTR data had some limitations. Certain information such as PMD type and helmet use was incomplete. Nevertheless, data quality was good for injury severity and need for hospital admission, data that is routinely collected by the NTR. Another limitation is that the NTR only captures data for patients who present to the emergency department of public hospitals, and hence our study findings may not apply to riders who self-medicate or see their family physician.
Acknowledgements
The authors would like to thank the National Trauma Committee, the National Trauma Registry working group, the National Trauma Unit, and other trauma database coordinators of the National Trauma Registry.
The following trauma co-ordinators and trauma service representatives from the Changi General Hospital, Khoo Teck Puat Hospital, National University Hospital, Ng Teng Fong General Hospital, Sengkang General Hospital, Singapore General Hospital and Tan Tock Seng Hospital, Singapore contributed to this paper:
Chee Keong, Chong. Changi General Hospital, Singapore.
Haslizah Bte Hassan. Changi General Hospital, Singapore.
Serena, Koh. Changi General Hospital, Singapore.
Yan, Li. Changi General Hospital, Singapore.
Kebing, Lin. Changi General Hospital, Singapore.
Nadhirah Binte Sani. Changi General Hospital, Singapore.
Peifu, Ng. Changi General Hospital, Singapore.
Christelle, Cha Sow King. Khoo Teck Puat Hospital, Singapore.
Tiong Thye, Goo. Khoo Teck Puat Hospital, Singapore.
Woan Wui, Lim. Khoo Teck Puat Hospital, Singapore.
Michael, Liu. Khoo Teck Puat Hospital, Singapore.
Sanjay, Patel. Khoo Teck Puat Hospital, Singapore.
Hong Chuen, Toh. Khoo Teck Puat Hospital, Singapore.
Suat Ting, Lim. National University Hospital, Singapore.
Tian Zhi, Lim. National University Hospital, Singapore.
Lynette Mee Ann, Loo. National University Hospital, Singapore.
Sabrina Siok Buay, Yeo. National University Hospital, Singapore.
Antony, Gardner. Ng Teng Fong General Hospital, Singapore.
Kai Yin, Hwang. Ng Teng Fong General Hospital, Singapore.
Noor’Aini Binte Nordin. Ng Teng Fong General Hospital, Singapore.
Yee Kent, Liew. Sengkang General Hospital, Singapore.
Jen Heng, Pek. Sengkang General Hospital, Singapore.
Pei Leng, Chong. Singapore General Hospital, Singapore.
Norhayati Mohamed Jainodin, Singapore General Hospital, Singapore.
Seo Kiat, Goh. Singapore General Hospital, Singapore.
Chung Fai Jeremy, Ng. Singapore General Hospital, Singapore.
Teng Teng, Fiona, Peh. Singapore General Hospital, Singapore.
Mann Hong, Tan. Singapore General Hospital, Singapore.
Choon Peng Jeremy, Wee. Singapore General Hospital, Singapore.
Yew Lok, Woo. Singapore General Hospital, Singapore.
Jolene YX, Cheng. Tan Tock Seng Hospital, Singapore.
Karen Tsung Shyen, Go. Tan Tock Seng Hospital, Singapore.
Serene SN, Goh. Tan Tock Seng Hospital, Singapore.
Xin Yi, Leong. Tan Tock Seng Hospital, Singapore.
Li-Tserng, Teo. Tan Tock Seng Hospital, Singapore.